Bank of America’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bank of America’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-9,139	Closed	-$221K	–	8477
2014 Q2	$221K	Buy	9,139 +6,847	+299%	+$71.4K	﹤0.01%	5464
2014 Q1	$14K	Sell	2,292 -179,997	-99%	-$1.26M	﹤0.01%	7088
2013 Q4	$1.09M	Sell	182,289 -407,495	-69%	-$1.89M	﹤0.01%	3971
2013 Q3	$3.06M	Buy	589,784 +552,613	+1,487%	+$2.42M	﹤0.01%	2838
2013 Q2	$134K	Buy	+37,171	New	+$152K	﹤0.01%	5972

Bank of America's IDIX Position: Q3 2014 in Review

Bank of America sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 9,139 shares — an estimated $221K sold.

Bank of America first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $3.06M in Q3 2013. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Bank of America reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Bank of America sold 9,139 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $221K.
Bank of America first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Bank of America's IDENIX PHARMACEUTICALS INC position peaked at $3.06M in Q3 2013.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Bank of America's 13F filing for Q3 2014, filed 14 Nov 2014.